chromium(3+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×4“Fasting glucose was lower in the 19.2-micromol group after 2 and 4 months (4-month values: placebo, 8.8 +/- 0.3 mmol/l; 19.2 micromol Cr, 7.1 +/- 0.2 mmol/l).”
Quoted verbatim from Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.. - Study
- RCT
- Duration
- 4 months
- Dose
- 19.2 micromol Cr per day (about 1,000 microg/day)
- Population
- 180 men and women being treated for type 2 diabetes, continuing their normal medications; highest-dose group (19.2 micromol Cr per day) versus placebo
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.1997PMID:9356027Permalink
Keep reading
- Everything the graph holds on chromium(3+)
- Every compound studied against Fasting blood glucose
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5MWNV5CSG3FN86AY91TWNTF